Почетна › Плоскоклеточни карцином главе и врата › Њујорк › New York City
Kliničke studije za Плоскоклеточни карцином главе и врата u gradu New York City, NY
42 studija za Плоскоклеточни карцином главе и врата traži učesnike na lokacijama u gradu New York City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Тражи се учесникФаза 2
- Mount Sinai Union Square, New York
- Mount Sinai Chelsea, New York
- Mount Sinai Hospital, New York
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Тражи се учесникФаза 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Тражи се учесникФаза 3
- Memorial Sloan Kettering Cancer Center, New York
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Тражи се учесникФаза 1
- Columbia University Irving Medical Center, New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Тражи се учесникФаза 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- и још 2
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Тражи се учесникФаза 3
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Тражи се учесникФаза 1/2
- Weill Cornell Medicine, Cornell University (site 126), New York
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Тражи се учесникФаза 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Mt. Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Тражи се учесникФаза 2/3
- Mount Sinai (Site #0155), New York
- Memorial Sloan Kettering Cancer Center (Site#0142), New York
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 2
- USA04-0, New York
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Тражи се учесникФаза 1/2
- NYU Langone Health, New York
- Icahn School of Medicine At Mount Sinai Prime, New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Research Site 107, New York
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
Тражи се учесникФаза 2
- Perlmutter Cancer Center at NYU Langone Health, New York
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 255132, New York
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
Тражи се учесникФаза 3
- NYU Langone Health Perlmutter Cancer Center, New York
- Memorial Sloan Kettering, New York
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Тражи се учесникФаза 1
- Memorial Sloan Kettering, New York
- Columbia University Herbert Irving Comprehensive Cancer Center, New York
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Тражи се учесникФаза 1
- Exelixis Clinical Site #60, New York
- Exelixis Clinical Site #6, New York
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Тражи се учесникФаза 1
- Research Site, New York
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center Head Neck Services, New York
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Тражи се учесникФаза 2
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 2
- Research Site, New York
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Mount Sinai, New York
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Тражи се учесникОпсервациона студија
- Mount Sinai Hospital, New York
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Тражи се учесникФаза 2/3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
Тражи се учесникФаза 2
- Mount Sinai Health System, New York
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Тражи се учесникФаза 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
- Columbia University Irving Medical Center, New York
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Тражи се учесникФаза 1
- NYU Laura and Isaac Perlmutter Cancer Center - 34th Street /ID# 257869, New York
A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment
Тражи се учесник
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Тражи се учесникФаза 3
- Manhattan Eye, Ear & Throat Hospital, New York
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Тражи се учесникФаза 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Тражи се учесникФаза 1/2
- NYU Langone Health, New York
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- NYMC, New York
Studije za Плоскоклеточни карцином главе и врата u drugim gradovima
- Houston, TX49 студија
- Nashville, TN43 студија
- Los Angeles, CA43 студија
- Boston, MA42 студија
- St. Louis, MO32 студија
- Chicago, IL29 студија
- Arlington, VA29 студија
- Philadelphia, PA25 студија
- Pittsburgh, PA23 студија
- Atlanta, GA22 студија
- New Haven, CT22 студија
- Dallas, TX22 студија
Ostale studije u gradu New York City
- Рак дојке144 студија
- Немалоклетни карцином плућа123 студија
- Рак (све врсте)105 студија
- Рак простате101 студија
- Метастатски карцином93 студија
- Колоректални карцином86 студија
- Рак јајника75 студија
- Рак плућа60 студија
- Многи мијелом59 студија
- Рак панкреаса57 студија
- Карцином ендометријума54 студија
- Akutna mijeloidna leukemija51 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.